Abbott (NYSE: ABT) recently reported its Q4 results, with revenues marginally below and earnings meeting the street expectations. The company reported revenue of $10.97 billion and earnings of $1.34 ...

Abbott Laboratories (NYSE:ABT) has greatly exceeded the broader S&P 500 index this year, with its stock price increasing by 18% compared to the S&P 500’s 6% rise. This strong performance is due to the ...

Wall Street analysts have a 'strong buy' rating on ABT stock, with 12 out of 24 analysts giving it this rating in the last 90 days. We agree with such bullish sentiment. Despite some risks, ABT stock ...

Abbott Laboratories ABT recently made its FreeStyle Libre 3 Plus sensor available to Canadians living with diabetes. This latest generation glucose monitoring device features the world's smallest ...

Presented during Abt’s annual awards ceremony at its headquarters in Glenview, Illinois, the award recognizes Ryder Last Mile for delivering, through its qualified carrier network, more than 6,400 ...

Investors with an interest in Medical - Products stocks have likely encountered both Envista (NVST) and Abbott (ABT). But which of these two stocks offers value investors a better bang for their buck ...

Investors interested in Medical - Products stocks are likely familiar with Phibro Animal Health (PAHC) and Abbott (ABT). But which of these two stocks offers value investors a better bang for their ...